Iterum Therapeutics (ITRM)
undefined
undefined%
At close: undefined
1.96
2.35%
After-hours Jan 03, 2025, 05:40 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a n/a n/a n/a 37.00K 869.00K 508.00K n/a
Cost of Revenue 1.75M 1.80M 2.10M 161.00K n/a n/a n/a n/a
Gross Profit -1.75M -1.80M -2.10M -161.00K 37.00K 869.00K 508.00K n/a
Operating Income -47.47M -30.38M -24.54M -32.13M -102.02M -76.56M -29.45M -13.36M
Interest Income 1.43M 2.36K 4.53K 12.30K 861.00 n/a 277.00K n/a
Pretax Income -37.76M -44.13M -90.86M -51.26M -102.69M -76.58M -28.96M -13.35M
Net Income -38.37M -44.43M -91.56M -52.01M -103.13M -77.06M -29.41M -13.46M
Selling & General & Admin 7.48M 12.77M 13.82M 11.05M 11.28M 8.78M 4.46M 3.26M
Research & Development 38.24M 17.62M 10.71M 21.07M 90.77M 68.65M 25.50M 10.10M
Other Expenses n/a -16.85M 195.00K 213.00K 196.00K 401.00K 216.00K 8.00K
Operating Expenses 47.47M 30.38M 24.54M 32.13M 102.06M 77.43M 29.96M 13.36M
Interest Expense n/a 2.36M 5.55M 15.10M 861.00K 426.00K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 47.47M 30.38M 24.54M 32.13M 102.06M 77.43M 29.96M 13.36M
Income Tax 613.00K 301.00K 705.00K 743.00K 444.00K 472.00K 444.00K 113.00K
Shares Outstanding (Basic) 12.96M 12.24M 163.37M 24.01M 14.52M 582.27K 506.28K 506.28K
Shares Outstanding (Diluted) 12.96M 12.24M 163.37M 24.01M 14.52M 582.27K 506.28K 506.28K
EPS (Basic) -2.96 -3.63 -0.56 -2.17 -7.1 -132.34 -58.08 -26.59
EPS (Diluted) -2.96 -3.63 -0.56 -2.17 -7.1 -132.34 -58.08 -26.59
EBITDA -34.58M -39.97M -83.20M -36.01M -101.67M -76.02M -29.39M -13.35M
Depreciation & Amortization 1.75M 1.80M 2.10M 161.00K 152.00K 136.00K 65.00K 13.36M